Peter Sartipy
AstraZeneca R&D
Moelndal, O, Sweden
Moelndal, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
Journal: European heart journal
Published: April 14, 2023
Data Mining Identifies CCN2 and THBS1 as Biomarker Candidates for Cardiac Hypertrophy.
Journal: Life (Basel, Switzerland)
Published: April 20, 2022
Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy.
Journal: Life (Basel, Switzerland)
Published: January 14, 2022
Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure.
Journal: Frontiers in cardiovascular medicine
Published: August 04, 2021
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
Journal: European journal of heart failure
Published: May 13, 2021
Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline.
Journal: Data in brief
Published: January 18, 2021
Cardiac hypertrophy in a dish: a human stem cell based model.
Journal: Biology open
Published: September 04, 2020
Multi-assignment clustering: Machine learning from a biological perspective.
Journal: Journal of biotechnology
Published: June 17, 2020
Correction of anemia by dapagliflozin in patients with type 2 diabetes.
Journal: Journal of diabetes and its complications
Published: May 06, 2020
Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials.
Journal: Journal of diabetes and its complications
Published: May 09, 2019
The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis.
Journal: Diabetes, obesity & metabolism
Published: April 21, 2019
Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models.
Journal: Stem cell reviews and reports
Published: October 22, 2018
Last Updated: 09/26/2026